Open-Label Placebo Studied in Children With Abdominal Pain, IBS

FRIDAY, Feb. 11, 2022 -- Open-label placebo (OLP) may have a beneficial effect for the treatment of functional abdominal pain or irritable bowel syndrome in children and adolescents, according to a study published online Jan. 31 in JAMA...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news